Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06306183 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Vitamin C on Pain Reduction After an Emergency Department Visit

Study acronym: Vicamed
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: details revised at 4 of 9 entriesv4
  2. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 10 more changesShow less
    • Enrollment target: 546 to 204
    • Primary completion date: Dec 2027 to Dec 2028
    • Primary endpoint revised
    • Study sites: 1 to 4
    • Study completion date: Jun 2028 to Dec 2029
    • Start date changed from estimate of Jun 2025 to Sep 1, 2025
    • Interventions: Acetaminophen and Placebo with Naproxen rescue (Other), Acetaminophen and Vitamin C with Naproxen rescue (Dietary Supplement) to Placebo (Other), Vitamin C (Dietary Supplement)
    • Eligibility criteria shortened, about 9 words
    • Secondary endpoints revised (9)
    • Study description shortened, about 47 words
  3. Notable Primary completion date: Nov 2026 to Dec 2027
    • Start date: Nov 2024 to Jun 2025
    • Study completion date: Mar 2028 to Jun 2028
    v2
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Musculoskeletal (MSK) injuries such as sprains, strains, bruises, and fractures are among the most common reasons people visit the emergency department. These injuries often cause significant pain in the first few days, making it difficult to move, work, or sleep. Usual pain medications like ibuprofen or acetaminophen can help, but they are not safe or effective for everyone. Some people cannot take them because of heart, kidney, stomach, or liver problems. Others still experience strong pain despite treatment. Because of these limits, some patients receive opioids, which can cause side effects and carry a risk of dependence. Safer and more accessible options are needed. Vitamin C is widely known for supporting the immune system, but research suggests it may also help reduce pain and inflammation. Studies in surgical patients have shown that vitamin C can lower pain levels, reduce the need for opioids, and support healing. These effects may be linked to its antioxidant properties and its role in tissue repair. However, no study has tested whether vitamin C can help people with recent MSK injuries treated in the emergency department. The VICAMED study aims to answer this question. Adults arriving with an MSK injury that occurred within the past 48 hours can participate if they have at least moderate pain. Participants are randomly assigned to receive either vitamin C or a placebo. The first dose is given in the emergency department, followed by twice daily capsules for three days. Pain is measured using a simple 0-100 scale, recorded in an electronic or paper diary. A follow-up on day six helps the research team understand each participant's recovery, medication use, and overall experience. Vitamin C is inexpensive, widely available, and very safe at the doses used in this study. If it proves effective, it could offer a simple, low risk option to help patients manage pain after an MSK injury and reduce the need for opioids in emergency care.
Trial Details
NCT Number NCT06306183
Lead Sponsor Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Collaborators: Hopital de l'Enfant-Jesus, The Ottawa Hospital
Conditions
(from sponsor)
Pain, Acute
Related terms Acute Pain, Emergencies, Pain
Enrollment 204 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov